CONMED Interest Debt Per Share from 2010 to 2025

CNMD Stock  USD 58.80  1.55  2.57%   
CONMED's Interest Debt Per Share is increasing over the years with slightly volatile fluctuation. Overall, Interest Debt Per Share is expected to go to 32.10 this year. During the period from 2010 to 2025 CONMED Interest Debt Per Share annual values regression line had geometric mean of  13.97 and mean square error of  12.20. View All Fundamentals
 
Interest Debt Per Share  
First Reported
2010-12-31
Previous Quarter
30.57375349
Current Value
32.1
Quarterly Volatility
11.63715908
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CONMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CONMED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 75.4 M, Interest Expense of 39.2 M or Selling General Administrative of 210 M, as well as many indicators such as Price To Sales Ratio of 0.98, Dividend Yield of 0.0135 or PTB Ratio of 1.3. CONMED financial statements analysis is a perfect complement when working with CONMED Valuation or Volatility modules.
  
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

Latest CONMED's Interest Debt Per Share Growth Pattern

Below is the plot of the Interest Debt Per Share of CONMED over the last few years. It is CONMED's Interest Debt Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CONMED's overall financial position and show how it may be relating to other accounts over time.
Interest Debt Per Share10 Years Trend
Slightly volatile
   Interest Debt Per Share   
       Timeline  

CONMED Interest Debt Per Share Regression Statistics

Arithmetic Mean19.15
Geometric Mean13.97
Coefficient Of Variation60.75
Mean Deviation10.04
Median18.11
Standard Deviation11.64
Sample Variance135.42
Range35.3795
R-Value0.96
Mean Square Error12.20
R-Squared0.92
Slope2.34
Total Sum of Squares2,031

CONMED Interest Debt Per Share History

2025 32.1
2024 30.57
2023 33.62
2022 36.08
2021 24.69
2020 28.69
2019 28.65

About CONMED Financial Statements

CONMED stakeholders use historical fundamental indicators, such as CONMED's Interest Debt Per Share, to determine how well the company is positioned to perform in the future. Although CONMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in CONMED's assets and liabilities are reflected in the revenues and expenses on CONMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CONMED. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Debt Per Share 30.57  32.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.028
Dividend Share
0.8
Earnings Share
4.25
Revenue Per Share
42.372
Quarterly Revenue Growth
0.058
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.